28
Oct
2025

Adragos Pharma GmbH

Exhibitor at CPHI Frankfurt 2025 stand 5.0C50, Contract Manufacturing and Services
About Us

Adragos pharma is a global CDMO headquartered in Munich, Germany, they are committed to fulfilling the pharmaceutical needs of clients throughout Europe, Japan and North America. Their approach is rooted in a customer-centric philosophy that guarantees exceptional quality and service in every aspect."

  • DE
  • 2019
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.0C50, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • L-A-W Service GmbH  | CDMO - Ointments, Cremes, Lotions

    Product L-A-W Service GmbH | CDMO - Ointments, Cremes, Lotions

    LAW Services a company of Adragos Pharma Group.  Contract manufacturing of prescription and OTC medicines, medical products and cosmetics.  • GMP compliant production of semi-solid and liquid dosage forms • GMP compliant confectioning of solid, semi-solid and liquid dosage forms • We are a...
  • Haupt Pharma Livron S.A.S. | CDMO - Ampoules and Suppositories

    Product Haupt Pharma Livron S.A.S. | CDMO - Ampoules and Suppositories

    Haupt Pharma Livron S.A.S. a company of Adragos Pharma Group. With our full service ranging from pharmaceutical development, materials procurement, production and packaging we offer customized solutions for injectable ampoules and suppositories. One of the core competencies of Haupt Pharma Livron...
  • Haupt Pharma Toride Co. Ltd. | Inspection and Packaging Vials, Ampoules and Patches

    Product Haupt Pharma Toride Co. Ltd. | Inspection and Packaging Vials, Ampoules and Patches

    Haupt Pharma Toride Co. Ltd. is a company of Adragos Pharma Group. Haupt Pharma Toride offers inspection, labeling and packaging solutions especially for vials and ampoules and meets the high quality standards of the Japanese pharmaceutical market. 


    For further information please contact ...